Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient
VEINVIEW
1 other identifier
interventional
2
1 country
1
Brief Summary
Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in anaesthesia and perhaps even in the field of medicine as a whole.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedStudy Start
First participant enrolled
March 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 21, 2018
August 1, 2018
1.4 years
September 5, 2016
August 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
duration of the PVC placement procedure
the time between the first puncture and the confirmation of successful PVC placement via the injection of physiological saline
Day 0
Study Arms (2)
control group
NO INTERVENTIONPVC placement performed in the usual manner: visual inspection of the patient's anatomy
visualisation group
EXPERIMENTALa skin transilluminator (such as the VeinViewer®Vision) is used to guide PVC placement
Interventions
Eligibility Criteria
You may qualify if:
- All obese adult patients scheduled for surgery.
- Social security coverage
You may not qualify if:
- Age \<18.
- Contra-indication to PVC placement.
- Legal guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
Study Officials
- PRINCIPAL INVESTIGATOR
Youssef ALAMI CHENTOUFI, MD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
March 21, 2017
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 21, 2018
Record last verified: 2018-08